"El Laboratorio Elea Phoenix es una empresa argentina que desde 1939 investiga, produce y distribuye medicamentos confiables para diversas especialidades médicas."

During the past decade, Laboratorio Elea SACIFyA conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Laboratorio Elea SACIFyA" are "Acquired Immunodeficiency Syndrome" (1 trials), "Nonrecurrent Condyloma" (1 trials) and "Recurrent Condyloma" (1 trials). Many other conditions were trialed in "Laboratorio Elea SACIFyA" in a lesser frequency.

Most popular intervention types in "Laboratorio Elea SACIFyA" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "PROAPOPTOTIC PEPTIDE CIGB 300" (1 trials) and "Tenofovir disoproxil fumarate and emtricitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Laboratorio Elea SACIFyA" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Laboratorio Elea SACIFyA". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Laboratorio Elea SACIFyA, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Laboratorio Elea SACIFyA, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".